Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Elevance Health Inc (ELV)

Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
What You Need To Know Ahead of Elevance Health’s Earnings Release

Elevance Health is scheduled to release its Q4 results next month, and analysts project a double-digit drop in profit.

XHS : 108.29 (+0.32%)
$SPX : 6,932.05 (+0.32%)
ELV : 343.30 (+0.02%)
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026

Elevance Health (NYSE: ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review...

ELV : 343.30 (+0.02%)
Stocks Supported by Strength in Cloud Stocks and Chip Makers

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.08%. March E-mini S&P futures...

MSTR : 158.71 (+0.53%)
AMAT : 260.78 (+0.21%)
AVGO : 350.22 (+0.26%)
GLXY : 24.43 (-0.65%)
LW : 42.48 (+1.63%)
$IUXX : 25,656.15 (+0.27%)
WYFI : 17.35 (-1.53%)
COIN : 239.73 (-1.06%)
ELV : 343.30 (+0.02%)
ZNH26 : 112-165s (+0.19%)
KBH : 57.42 (+1.04%)
CRWV : 78.87 (-1.73%)
Winners And Losers Of Q3: Elevance Health (NYSE:ELV) Vs The Rest Of The Health Insurance Providers Stocks

Winners And Losers Of Q3: Elevance Health (NYSE:ELV) Vs The Rest Of The Health Insurance Providers Stocks

ELV : 343.30 (+0.02%)
Elevance Health Reflects On The Changed Role of Health Plans

By simplifying the healthcare experience, improving care coordination, and leveraging data-driven insights, Elevance Health affiliated health plans help members navigate a range of healthcare experiences...

ELV : 343.30 (+0.02%)
AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded...

ELV : 343.30 (+0.02%)
Most Stocks Recover from Oracle Sell-Off

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up by +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +1.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.35%. December...

AMAT : 260.78 (+0.21%)
IPI : 28.30 (-0.67%)
AVGO : 350.22 (+0.26%)
OXM : 35.48 (+1.52%)
$IUXX : 25,656.15 (+0.27%)
ELV : 343.30 (+0.02%)
UNH : 327.58 (+0.86%)
ZNH26 : 112-165s (+0.19%)
CIEN : 240.28 (unch)
LOVE : 14.90 (+2.97%)
ESH26 : 6,982.50s (+0.31%)
NCLH : 23.17 (+0.26%)
2 S&P 500 Stocks to Research Further and 1 We Question

2 S&P 500 Stocks to Research Further and 1 We Question

ELV : 343.30 (+0.02%)
WMT : 111.61 (+0.64%)
HWM : 212.17 (+1.24%)
Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective...

ELV : 343.30 (+0.02%)
3 Cash-Producing Stocks Worth Investigating

3 Cash-Producing Stocks Worth Investigating

ALHC : 19.15 (-1.95%)
AMZN : 232.38 (+0.10%)
ELV : 343.30 (+0.02%)

Barchart Exclusives

This Dividend-Yielding Tech Stock Looks a ‘Compelling Buy’ for 2026 After 2 Years of Underperformance
Microsoft is set to underperform markets for the second consecutive year. Dan Ives of Wedbush, meanwhile, sees it as a “compelling” buy and predicts nearly 30% upside next year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar